Diabetes Mellitus: all 11,090 studies
Page 88 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Observational Study With Mixtard® 30 NovoLet® to Assess Patient SatisfactionCompletedNCT01492218
- NovoLet® Acceptance Study Within the Hospital Practise in IndonesiaCompletedNCT01492205
- Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical PracticeCompletedNCT01492166
- NovoLet® Surveillance Study on Using Human Insulin System in IndonesiaCompletedNCT01492153
- A Study to Evaluate a Multiple Model Probabilistic Predictive Controller (MMPPC) for Closed Loop Insulin DeliveryWithdrawnNCT01492062Not applicable
- Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy VolunteersCompletedNCT01490658Phase 1
- Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative OutcomesCompletedNCT01490619Not applicable
- Gestational Diabetes Mellitus and Cardiometabolic Syndrome in OffspringCompletedNCT01490372
- Surveillance Study of NovoRapid® for New Drug Re-examinationCompletedNCT01490112
- Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy VolunteersCompletedNCT01489644Phase 1
- Lifestyle Intervention Program for Women With Gestational Diabetes or Gestational Impaired Glucose ToleranceCompletedNCT01489163Not applicable
- Vitamin D Inadequacy on Postprandial Glucose in Type 2 Diabetes MellitusStatus unknownNCT01488916
- Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01487798Phase 4
- An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at BedtimeCompletedNCT01487421
- Special Survey for Type 1 or Type 2 Diabetic PatientsCompletedNCT01487408
- Special Survey for Paediatric SubjectsCompletedNCT01487382
- Special Survey of Production of Insulin Aspart Specific AntibodyCompletedNCT01487369
- Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCompletedNCT01486940Phase 3
- Observational Study of Safety of NovoMix® 30 Treatment for Type 2 DiabetesCompletedNCT01486875
- Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADsCompletedNCT01486862Phase 4
- Silastic Ring Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Obese PatientsCompletedNCT01486680Not applicable
- Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 DiabetesCompletedNCT01486381Phase 3
- Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention StudyCompletedNCT01486290Not applicable
- Controlled Insulin Delivery: Combining Technology With TreatmentCompletedNCT01484457Early Phase 1
- Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2CompletedNCT01484262
- A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes MellitusCompletedNCT01483781Phase 1
- Effectiveness of Nursing Care Plans Based in Nursing Diagnoses in Metabolic Control of Type 2 Diabetes MellitusCompletedNCT01482481
- Diabetes Resolution and Hormone Changes After BPDLL and LSGCompletedNCT01481675
- Identification and Characterization of Monogenic DiabetesCompletedNCT01481623Not applicable
- Evaluation of Posterior Capsule Opacification in Eyes With Diabetes MellitusCompletedNCT01480934
- Prevention of Diabetes Mellitus Type 2 in Women Post Gestational Diabetes Mellitus DiagnosisCompletedNCT01480895Not applicable
- Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention StudyCompletedNCT01480804Not applicable
- Multi-Channel Automated Diet and Physical Activity Intervention for Pre-DiabeticsCompletedNCT01479062Not applicable
- Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 DiabetesWithdrawnNCT01477476Phase 2
- Vitamin D and Adipose Tissue InflammationCompletedNCT01477034Not applicable
- Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes MellitusCompletedNCT01475552Phase 4
- Effectiveness of the Self Monitoring of Capillary Blood Glucose at HomeStatus unknownNCT01475422Not applicable
- Managing Diabetes During Pregnancy in the Wireless AgeStatus unknownNCT01474525Not applicable
- Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505CompletedNCT01474161Phase 1
- A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 DiabetesCompletedNCT01474083Phase 1/2
- Structured Diabetes Self-Management Education in Primary Care and Metabolic ControlCompletedNCT01473329Not applicable
- Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic PatientsCompletedNCT01473147Not applicable
- Improving Mental Health in Diabetes: A Guided Self-Help StudyWithdrawnNCT01473017Not applicable
- Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes MellitusCompletedNCT01472614Phase 3
- Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)CompletedNCT01472406Early Phase 1
- Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 DiabetesCompletedNCT01472328Not applicable
- Chinese Medicine Treatment of Obesity With Type 2 Diabetes, DyslipidemiaStatus unknownNCT01471275Not applicable
- Early Diabetes Intervention ProgramCompletedNCT01470937Phase 4
- A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 DiabetesCompletedNCT01469143Phase 1
- Metabolic Response to 3-day Fast Versus Carbohydrate-free Diet in Type 2 DiabetesCompletedNCT01469104Not applicable
- Exploratory CSII Trial on Erectile Dysfunction in T2DM PatientsCompletedNCT01468519Phase 4
- The Effect Of Glycemic Control On Malondialdehyde, Glutathione Peroxidase, Glutathione And ParaoxonaseCompletedNCT01467674
- A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 DiabetesTerminatedNCT01467414Phase 1
- Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 DiabetesCompletedNCT01467401Phase 4
- Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01467375Phase 3
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 DiabetesCompletedNCT01467323Phase 3
- Safety and Efficacy of Insulin Aspart in Children With Type 1 DiabetesCompletedNCT01467141Phase 4
- Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 DiabetesCompletedNCT01465152Phase 4
- AMG 151 Amgen Protocol Number 20100761CompletedNCT01464437Phase 2
- Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 DiabetesCompletedNCT01464099Phase 1
- Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP AxisCompletedNCT01461616Phase 3
- Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) FailureCompletedNCT01461577Phase 4
- Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 DiabetesStatus unknownNCT01460459Not applicable
- Improving Access to HbA1c in Sub Saharan AfricaCompletedNCT01460095Not applicable
- Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsCompletedNCT01459809Phase 3
- Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere Inhalation SystemWithdrawnNCT01459133Not applicable
- Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With MetforminCompletedNCT01457911Phase 3
- Educative Intervention to Improve Type 2 Diabetes Mellitus Control in CorrientesCompletedNCT01456806Not applicable
- Effects of Food Advanced Glycation Endproducts on Vascular Function in DiabetesCompletedNCT01456026Not applicable
- A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 DiabetesWithdrawnNCT01455922Phase 3
- A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 DiabetesWithdrawnNCT01455909Phase 3
- A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650CompletedNCT01455896Phase 3
- A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 DiabetesWithdrawnNCT01455883Phase 3
- A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 DiabetesCompletedNCT01455870Phase 3
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 DiabetesCompletedNCT01455857Phase 3
- Pharmaceutical Care of Ambulatory Elderly Diabetes PatientsCompletedNCT01455727Not applicable
- The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 DiabetesCompletedNCT01455441Phase 4
- A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 DiabetesCompletedNCT01455142Phase 1
- Effect of CSII and CGM on Progression of Late Diabetic ComplicationsCompletedNCT01454700Phase 4
- Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical PracticeCompletedNCT01454024
- Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II DiabetesWithdrawnNCT01453751Not applicable
- Counterregulatory Hormone Production in Adrenal Insufficiency and Diabetes Type ICompletedNCT01452893
- Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic GastroparesisCompletedNCT01452815Phase 2
- Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes MellitusCompletedNCT01452451Phase 2
- Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) TherapyCompletedNCT01452113Phase 2
- Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 DiabetesCompletedNCT01449773Not applicable
- The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)CompletedNCT01449019Phase 1
- Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - PadovaCompletedNCT01447992Early Phase 1
- Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - MontpellierCompletedNCT01447979Early Phase 1
- Caloric Restriction and Insulin SecretionCompletedNCT01447524Not applicable
- Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep ApneaCompletedNCT01447251Not applicable
- Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes SubjectsCompletedNCT01441986Phase 2
- Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes MellitusCompletedNCT01441921Not applicable
- Home Versus Hospital Care in Glucose Monitoring of Gestational Diabetes and Mild Gestational HyperglycemiaCompletedNCT01441518Phase 2
- A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 DiabeticsCompletedNCT01441232Phase 1
- Technology Intervention for Diabetes Engagement & Self-Care (TIDES)CompletedNCT01440530Not applicable
- Comparing Long-acting Insulins During Exercise in Type 1 DiabetesStatus unknownNCT01440439Phase 4
- A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and AlbuminuriaCompletedNCT01440257Phase 2
- Closing the Loop in Adults With Type 1 Diabetes in the Home SettingCompletedNCT01440140Phase 2
- Pharmacology of Insulin Injected With Jet-injection in DiabetesCompletedNCT01438632Phase 4